Innovation, Memory, Prevention

When One Door Closes

What the Failure of Biogen’s Aducanumab Tells Us About Alzheimer’s — Risk Reduction is Still Our Best Weapon Today I serve as Neurotrack’s Head Writer. But three years ago, in a different professional incarnation, I had the privilege of sitting in a packed conference room with a bright, articulate representative from the pharmaceutical company Biogen […]

Read more

The everyday drug that might fight Alzheimer’s Disease

As a staple in our daily lives, coffee is most people’s primary source of caffeine. Coffee and caffeine have poured themselves so thoroughly into our routine that it’s easy to forget that it serves as a drug first and foremost. With 90% of Americans consuming some kind of caffeine on a daily basis, it is […]

Read more